Long-term response to vaccination against pneumococcal antigens in kidney transplant recipients

Transplantation

Volumn 94, Issue 1, 2012, Pages 50-56

  Lindemann, Monika ^a   Heinemann, Falko M ^a   Horn, Peter A ^a   Witzke, Oliver ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Kidney transplantation; Long term efficacy of vaccination; Luminex technology; Pneumococcal antigens; Serotype specific antibody response

Indexed keywords

AZATHIOPRINE; BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PNEUMOCOCCUS VACCINE; PREDNISONE; TACROLIMUS;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; DRUG EFFICACY; FEMALE; GRAFT RECIPIENT; HUMAN; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LONG TERM CARE; MALE; OUTCOME ASSESSMENT; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; PROTECTION; SEROTYPE;

ADULT; AGED; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; LOGISTIC MODELS; MALE; MIDDLE AGED; PNEUMOCOCCAL VACCINES; STREPTOCOCCUS PNEUMONIAE; TIME FACTORS; VACCINATION;

EID: 84863727661     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318250fc8c     Document Type: Article

References (30)

1. Centers for Disease Control and Prevention. Recommended adult immunization scheduleVUnited States, 2011. MMWR Morb Mortal Wkly Rep 2011; 60: 1.
2. Robert Koch-Institut. Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut. Epidemiol Bull 2011; 30: 275.
3. Lindemann M, Heinemann FM, Horn PA, et al. Immunity to pneumococcal antigens in kidney transplant recipients. Transplantation 2010; 90: 1463.
4. Klugman KP, Chien YW, Madhi SA. Pneumococcal pneumonia and influenza: a deadly combination. Vaccine 2009; 27(suppl 3): C9.
5. Butler JC. Epidemiology of pneumococcal disease. In: Tuomanen EI, Morrison DA, Spratt BG, eds. The Pneumococcus, Vol 10. Washington, DC: American Society for Microbiology; 2004: 148.
6. Rubins JB, Puri AK, Loch J, et al. Magnitude, duration, quality, and function of pneumococcal vaccine responses in elderly adults. J Infect Dis 1998; 178: 431.
7. Hausdorff WP, Feikin DR, Klugman KP. Epidemiological differences among pneumococcal serotypes. Lancet Infect Dis 2005; 5: 83.
8. Moberley SA, Holden J, Tatham DP, et al. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev 2008; 1: CD000422.
9. Borgers H, Moens L, Picard C, et al. Laboratory diagnosis of specific antibody deficiency to pneumococcal capsular polysaccharide antigens by multiplexed bead assay. Clin Immunol 2010; 134: 198.
10. Uddin S, Borrow R, Haeney MR, et al. Total and serotype-specific pneumococcal antibody titres in children with normal and abnormal humoral immunity. Vaccine 2006; 24: 5637.
11. Romero-Steiner S, Musher DM, Cetron MS, et al. Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity. Clin Infect Dis 1999; 29: 281.
12. Ortqvist A, Henckaerts I, Hedlund J, et al. Non-response to specific serotypes likely cause for failure to 23-valent pneumococcal polysaccharide vaccine in the elderly. Vaccine 2007; 25: 2445.
13. Boyle RJ, Le C, Balloch A, et al. The clinical syndrome of specific antibody deficiency in children. Clin Exp Immunol 2006; 146: 486.
14. Kumar D, Welsh B, Siegal D, et al. Immunogenicity of pneumococcal vaccine in renal transplant recipientsVthree year follow-up of a randomized trial. Am J Transplant 2007; 7: 633.
15. Mufson MA, Krause HE, Schiffman G. Long-term persistence of antibody following immunization with pneumococcal polysaccharide vaccine. Proc Soc Exp Biol Med 1983; 173: 270.
16. Rytel MW, Dailey MP, Schiffman G, et al. Pneumococcal vaccine immunization of patients with renal impairment. Proc Soc Exp Biol Med 1986; 182: 468.
17. Marrie TJ, Schiffman G, Bortolussi R, et al. Humoral immune response of kidney transplant recipients to pneumococcal vaccine. Proc Soc Exp Biol Med 1981; 167: 62.
18. Giebink GS, Le CT, Cosio FG, et al. Serum antibody responses of high-risk children and adults to vaccination with capsular polysaccharides of Streptococcus pneumoniae. Rev Infect Dis 1981; 3: S168.
19. Esposito S, Droghetti R, Faelli N, et al. Serum concentrations of pneumococcal anticapsular antibodies in childrenwith pneumonia associated with Streptococcus pneumonia infection. Clin Infect Dis 2003; 37: 1261.
20. Jeurissen A, Moens L, Raes M, et al. Laboratory diagnosis of specific antibody deficiency to pneumococcal capsular polysaccharide antigens. Clin Chem 2007; 53: 505.
21. Imohl M, Reinert RR, van der Linden M. Temporal variations among invasive pneumococcal disease serotypes in children and adults in Germany (1992Y2008). Int J Microbiol 2010; 2010: 874189.
22. Fuchshuber A, Kuhnemund O, Keuth B, et al. Pneumococcal vaccine in children and young adults with chronic renal disease. Nephrol Dial Transplant 1996; 11: 468.
23. Vernacchio L, Romero-Steiner S, Martinez JE, et al. Comparison of an opsonophagocytic assay and IgG ELISA to assess responses to pneumococcal polysaccharide and pneumococcal conjugate vaccines in children and young adults with sickle cell disease. J InfectDis 2000; 181: 1162.
24. Pourfarziani V, Ramezani MB, Taheri S, et al. Immunogenicity of pneumococcal vaccination in renal transplant recipients and hemodialysis patients: a comparative controlled trial. Ann Transplant 2008; 13: 43.
25. Silberman H, Overturf GD, Field RJ, et al. Response of renal allograft recipients to pneumococcal vaccine. Ann Surg 1980; 192: 199.
26. Arnold WC, Steele RW, Rastogi SP, et al. Response to pneumococcal vaccine in renal allograft recipients. Am J Nephrol 1985; 5: 30.
27. Heidt S, Roelen DL, Eijsink C, et al. Calcineurin inhibitors affect B cell antibody responses indirectly by interfering with T cell help. Clin Exp Immunol 2010; 159: 199.
28. Heidt S, Roelen DL, Eijsink C, et al. Effects of immunosuppressive drugs on purified human B cells: evidence supporting the use of MMF and rapamycin. Transplantation 2008; 86: 1292.
29. Johnson SE, Rubin L, Romero-Steiner S, et al. Correlation of opsonophagocytosis and passive protection assays using human anticapsular antibodies in an infant mouse model of bacteremia for Streptococcus pneumoniae. J Infect Dis 1999; 180: 133.
30. Landesman SH, Schiffman G. Assessment of the antibody response to pneumococcal vaccine in high-risk populations. Rev Infect Dis 1981; (3 suppl): S184.